Netherlands Country Drug Report 2019

Key statistics

Most recent estimates and data reported

  EU range
  Year Country data Min. Max.

There are no data available on the number of seizures. Data on quantity of seizures do not include all relevant law enforcement units and should be considered partial, minimum figures. Cocaine seizures are assumed to represent the majority of large seizures. Further details on the scope of supply data may be found in the methodological note . The potency - Herbal (% THC) refers to imported cannabis; the purity of domestic grown weed, also called Nederwiet ranges between min. 4, max. 57 and purity of domestic grown Hashish, also called Nederhasj ranges between min. 0.8, max. 60.4. Mean price per gram of herbal cannabis is estimated at € 4.04, and the mean price of cannabis resin at € 9.43. Purity amphetamines correspond to FT-IR results. The number of Clients in opioid substitution treatment is incomplete and does not represent the national picture.

Cannabis
Lifetime prevalence of use — schools (% , Source: ESPAD) 2015 22.37 6.51 36.79
Last year prevalence of use — young adults (%) 2017 17.5 1.8 21.8
Last year prevalence of drug use — all adults (%) 2017 9.2 0.9 11
All treatment entrants (%) 2015 47.3 1.03 62.98
First-time treatment entrants (%) 2015 55.5 2.3 74.36
Quantity of herbal cannabis seized (kg) 2017 3 104 11.98 94 378.74
Number of herbal cannabis seizures n.a. n.a. 57 151 968
Quantity of cannabis resin seized (kg) 2017 942 0.16 334 919
Number of cannabis resin seizures n.a. n.a. 8 157 346
Potency — herbal (% THC) (minimum and maximum values registered) 2017 2.5 - 11.8 0 65.6
Potency — resin (% THC) (minimum and maximum values registered) 2017 7.9 - 44.8 0 55
Price per gram — herbal (EUR) (minimum and maximum values registered) n.a. n.a. 0.58 64.52
Price per gram — resin (EUR) (minimum and maximum values registered) n.a. n.a. 0.15 35
Cocaine
Lifetime prevalence of use — schools (% , Source: ESPAD) 2015 1.94 0.85 4.85
Last year prevalence of use — young adults (%) 2017 4.5 0.1 4.7
Last year prevalence of drug use — all adults (%) 2017 2.2 0.1 2.7
All treatment entrants (%) 2015 24.3 0.14 39.2
First-time treatment entrants (%) 2015 20.8 0 41.81
Quantity of cocaine seized (kg) 2017 14 629 0.32 44 751.85
Number of cocaine seizures n.a. n.a. 9 42 206
Purity (%) (minimum and maximum values registered) 2017 1 - 89 0 100
Price per gram (EUR) (minimum and maximum values registered) n.a. n.a. 2.11 350
Amphetamines
Lifetime prevalence of use — schools (% , Source: ESPAD) 2015 2.41 0.84 6.46
Last year prevalence of use — young adults (%) 2017 3.9 0 3.9
Last year prevalence of drug use — all adults (%) 2017 1.8 0 1.8
All treatment entrants (%) 2015 7.4 0 49.61
First-time treatment entrants (%) 2015 7.5 0 52.83
Quantity of amphetamine seized (kg) 2017 122 0 1 669.42
Number of amphetamine seizures n.a. n.a. 1 5 391
Purity — amphetamine (%) (minimum and maximum values registered) 2017 15 - 75 0.07 100
Price per gram — amphetamine (EUR) (minimum and maximum values registered) n.a. n.a. 3 156.25
MDMA
Lifetime prevalence of use — schools (% , Source: ESPAD) 2015 3.1 0.54 5.17
Last year prevalence of use — young adults (%) 2017 7.1 0.2 7.1
Last year prevalence of drug use — all adults (%) 2017 3.3 0.1 3.3
All treatment entrants (%) 2015 0.7 0 2.31
First-time treatment entrants (%) 2015 1 0 2.85
Quantity of MDMA seized (tablets) 2017 n.a. 159 8 606 765
Number of MDMA seizures n.a. n.a. 13 6 663
Purity (MDMA mg per tablet) (minimum and maximum values registered) 2017 2 - 278 0 410
Purity (MDMA % per tablet) (minimum and maximum values registered) n.a. n.a. 2.14 87
Price per tablet (EUR) (minimum and maximum values registered) n.a. n.a. 1 40
Opioids
High-risk opioid use (rate/1 000) 2012 1.26 0.48 8.42
All treatment entrants (%) 2015 11.5 3.99 93.45
First-time treatment entrants (%) 2015 6.2 1.8 87.36
Quantity of heroin seized (kg) 2017 1 110 0.01 17 385.18
Number of heroin seizures n.a. n.a. 2 12 932
Purity — heroin (%) (minimum and maximum values registered) 2017 16 - 78 0 91
Price per gram — heroin (EUR) (minimum and maximum values registered) n.a. n.a. 5 200
Newly diagnosed HIV cases related to injecting drug use (cases/million population, Source: ECDC) 2017 0.1 0 47.8
HIV prevalence among PWID* (%) 2017 n.a. 0 31.1
HCV prevalence among PWID* (%) 2017 n.a. 14.7 81.5
Injecting drug use (cases rate/1 000 population) 2015 0.08 0.08 10.02
Drug-induced deaths — all adults (cases/million population) 2017 21.81 2.44 129.79
Health and social responses
Syringes distributed through specialised programmes n.a. n.a. 245 11 907 416
Clients in substitution treatment 2015 5 241 209 178 665
Treatment demand
All entrants 2015 10 987 179 118 342
First-time entrants 2015 6 529 48 37 577
All clients in treatment 2015 31 115 1 294 254 000
Drug law offences
Number of reports of offences 2017 18 687 739 389 229
Offences for use/possession n.a. n.a. 130 376 282

Netherlands main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.

Additional note for the Netherlands: Data on number and quantity of seizures do not include all relevant law enforcement units and should be considered partial, minimum figures. Data for amphetamines, heroin and MDMA include seizures by Dutch Customs and the Royal Military Police, but do not include seizures by national or regional police forces. Cocaine seizures represent the majority of large seizures, comprising data from Dutch Customs (including Rotterdam and Vlissingen harbours), the Royal Military Police and the National Police Force, but regional police force data are not included. Cannabis data are limited to police seizures of plants, cuttings and tops seized during dismantlement of cultivation sites. Data on precursors (scheduled and non-scheduled substances) are based exclusively on reports of suspicious transactions of such substances to the Fiscal Intelligence and Investigation Unit.